XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.23.2

DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES | 6 Months Ended
--- | ---
Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIES | DERIVATIVE INSTRUMENTS AND HEDGING STRATEGIESThe Company uses foreign currency exchange forward contracts (forward contracts) to protect against the impact of changes in the value of forecasted foreign currency cash flows resulting from revenues and operating expenses denominated in currencies other than the U.S. Dollar (USD), primarily the Euro. Certain of these forward contracts are designated as cash flow hedges and have maturities of up to two years. The Company also enters into forward contracts to manage foreign exchange risk related to asset or liability positions denominated in currencies other than USD. Such forward contracts are considered to be economic hedges, are not designated as hedging instruments and have maturities of up to three months. The Company does not use derivative instruments for speculative trading purposes. The Company is exposed to counterparty credit risk on its derivatives. The Company has established and maintains strict counterparty credit guidelines and enters into hedging agreements with financial institutions that are investment grade or better to minimize the Company’s exposure to potential defaults. The Company is not required to pledge collateral under these agreements. The following table summarizes the aggregate notional amounts for the Company’s derivatives outstanding as of the periods presented.
Forward Contracts | June 30, 2023 |  | December 31, 2022
Derivatives designated as hedging instruments: |  |  |
Sell | $ | 745,960 |  |  | $ | 808,635 |
Purchase | $ | 154,649 |  |  | $ | 177,393 |
Derivatives not designated as hedging instruments: |  |  |
Sell | $ | 308,486 |  |  | $ | 218,903 |
Purchase | $ | 21,479 |  |  | $ | 6,785 |
The fair value carrying amounts of the Company’s derivatives, which are classified as Level 2 within the fair value hierarchy, were as follows:
Balance Sheet Location | June 30, 2023 |  | December 31, 2022
Derivatives designated as hedging instruments: |  |  |
Asset Derivatives |  |  |
Other current assets | $ | 13,659 |  |  | $ | 19,464 |
Other assets | 1,728 |  |  | 2,059 |
Subtotal | $ | 15,387 |  |  | $ | 21,523 |
Liability Derivatives |  |  |
Accounts payable and accrued liabilities | $ | 18,445 |  |  | $ | 12,130 |
Other long-term liabilities | 5,252 |  |  | 1,074 |
Subtotal | $ | 23,697 |  |  | $ | 13,204 |
Derivatives not designated as hedging instruments: |  |  |
Asset Derivatives |  |  |
Other current assets | $ | 3,448 |  |  | $ | 1,472 |
Liability Derivatives |  |  |
Accounts payable and accrued liabilities | $ | 1,127 |  |  | $ | 471 |
Total Derivatives Assets | $ | 18,835 |  |  | $ | 22,995 |
Total Derivatives Liabilities | $ | 24,824 |  |  | $ | 13,675 |
For additional discussion of fair value measurements, see Note 1 – Business Overview and Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. The following tables summarize the impact of gains and losses from the Company's derivatives on its Condensed Consolidated Statements of Comprehensive Income for the periods presented.
| Three Months Ended June 30,
| 2023 |  | 2022
Derivatives Designated as Cash Flow Hedging Instruments |  | Cash Flow Hedging Gains (Losses) Reclassified into Earnings |  | Cash Flow Hedging Gains (Losses) Reclassified into Earnings
Net product revenues |  | $ | 677 |  |  | $ | 5,927 |
Operating expenses |  | $ | (26) |  |  | $ | (1,800) |
Derivatives Not Designated as Hedging Instruments |  | Gains (Losses) Recognized in Earnings |  | Gains (Losses) Recognized in Earnings
Operating expenses |  | $ | 769 |  |  | $ | 4,950 |
| Six Months Ended June 30,
| 2023 |  | 2022
Derivatives Designated as Cash Flow Hedging Instruments |  | Cash Flow Hedging Gains (Losses) Reclassified into Earnings |  | Cash Flow Hedging Gains (Losses) Reclassified into Earnings
Net product revenues |  | $ | 4,147 |  |  | $ | 11,499 |
Operating expenses |  | $ | (482) |  |  | $ | (3,179) |
Derivatives Not Designated as Hedging Instruments |  | Gains (Losses) Recognized in Earnings |  | Gains (Losses) Recognized in Earnings
Operating expenses |  | $ | (3,394) |  |  | $ | 6,241 |
As of June 30, 2023, the Company expects to reclassify unrealized losses of $6.5 million from Accumulated Other Comprehensive Income (AOCI) to earnings as the forecasted revenues and operating expense transactions occur over the next twelve months. For additional discussion of balances in AOCI see Note 7 – Accumulated Other Comprehensive Income.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//815/tableOfContent + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration